Comparable stake leader
JEFFERSON RIVER CAPITAL LLC
SEC ownership of Renalytix plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001811115.
Disclosed value leader
JEFFERSON RIVER CAPITAL LLC
Comparable rows
1/14
Latest evidence
04 Nov 2025
- Public ticker
- RNLXY on OTC
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
JEFFERSON RIVER CAPITAL LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 14
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
JEFFERSON RIVER CAPITAL LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
04 Nov 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001811115
- Issuer location
- London
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Renalytix plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JEFFERSON RIVER CAPITAL LLC
Disclosed value leader
JEFFERSON RIVER CAPITAL LLC
Comparable rows
1/14
Latest evidence
04 Nov 2025
13D/G
3/4/5
Lead comparable stake: 4.5%
13 rows are not safely comparable across share classes.
13D/G row: JEFFERSON RIVER CAPITAL LLC
Showing 1-8 of 14 holder rows.
Quick read
JEFFERSON RIVER CAPITAL LLC leads the comparable SEC ownership view at 4.5%.
1 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JEFFERSON RIVER CAPITAL LLC's linked filing trail.
Comparable ownership
Top 1
JEFFERSON RIVER CAPITAL LLC
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JEFFERSON RIVER CAPITAL LLC |
13D/G
|
4.5%
|
$82,899,330
19,644,391 shares
|
$0 | 04 Nov 2025 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$3,791,344
35,015,237 shares
mixed-class rows
|
— | 01 Nov 2024 |
| Christopher Mills |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$2,518,126
10,167,500 shares
mixed-class rows
|
— | 20 Nov 2023 |
| James Renwick McCullough |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$686,597
3,621,403 shares
mixed-class rows
|
— | 06 Jul 2023 |
| O James Sterling |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
$451,309
2,380,396 shares
mixed-class rows
|
— | 06 Jul 2023 |
| Fergus Fleming |
3/4/5
Chief Technical Officer, Director
|
—
mixed-class rows
|
$142,370
922,383 shares
mixed-class rows
|
— | 06 Jul 2023 |
| Timothy J. Scannell |
3/4/5
Director
|
—
class O/S missing
|
$17,241
68,964 shares
|
— | 01 Jul 2023 |
| Thomas H. Mclain |
3/4/5
President
|
—
mixed-class rows
|
$14,788
259,150 shares
mixed-class rows
|
— | 10 Jul 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 12 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to Renalytix plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Net 12M change
$0
Latest report
01 Nov 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 10%+ Owner | $3,791,344 | Mixed | 01 Nov 2024 | ||
| Christopher Mills | Director, 10%+ Owner | $2,518,126 | Mixed | 20 Nov 2023 | ||
| James Renwick McCullough | Chief Executive Officer, Director | $686,597 | Mixed | 06 Jul 2023 | ||
| O James Sterling | Chief Financial Officer | $451,309 | Mixed | 06 Jul 2023 | ||
| Fergus Fleming | Chief Technical Officer, Director | $142,370 | Mixed | 06 Jul 2023 | ||
| Timothy J. Scannell | Director | $17,241 | Mixed | 01 Jul 2023 | ||
| Thomas H. Mclain | President | $14,788 | Mixed | 10 Jul 2023 | ||
| Catherine Coste | Director | Mixed | 20 Nov 2023 | |||
| Daniel J. Levangie | Director | Mixed | 20 Nov 2023 | |||
| Chirag R. Parikh | Director | Mixed | 20 Nov 2023 | |||
| Michael J. Donovan | Chief Medical Officer | Mixed | 06 Jul 2023 | |||
| Howard Doran Jr. | Chief Business Officer | Mixed | 20 Nov 2023 | |||
| Erik Lium | Director | Mixed | 01 Jul 2023 | |||
| Joel R. Jung | Interim Chief Financial Office | Mixed | 11 Jun 2024 |
Recent insider transactions for Renalytix plc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.